Activation of the IGF signaling pathway may increase cancer cell proliferation, stimulate aggressive tumor behavior in established cancers [15], and confer resistance of cancer cells to cytotoxic and molecular targeting therapies [16]–[18]. The gene discussed is IGF1; the disease is neoplasm.